Herein, we establish the proof of principle that mouse natural cDC1s treated ex vivo with adjuvant and tumor-Ag for a very short time are efficient to induce Ag-specific anti-cancer CD8+ and CD4+ T cell responses in vivo. The gene discussed is CD4; the disease is cancer.